Possible involvement of a magnesium dependent mitochondrial alkaline phosphatase in the regulation of the 25-hydroxyvitamin D3-1 alpha-and 25-hydroxyvitamin D3-24R-hydroxylases in LLC-PK1 cells - PubMed (original) (raw)
. 1994 Dec;7(3-4):169-78.
Affiliations
- PMID: 7540407
Possible involvement of a magnesium dependent mitochondrial alkaline phosphatase in the regulation of the 25-hydroxyvitamin D3-1 alpha-and 25-hydroxyvitamin D3-24R-hydroxylases in LLC-PK1 cells
F Risco et al. Magnes Res. 1994 Dec.
Abstract
It has been demonstrated that dephosphorylation of the ferredoxin component of the mitochondrial 25-hydroxyvitamin D3-1-hydroxylase, as a result of a PTH-cAMP mediated activation, involves a protein phosphatase activity. However, the nature and properties of this phosphatase are uncertain. It has been proved that alkaline phosphatase, a magnesium dependent enzyme, could dephosphorylate in vitro the ferredoxin component of the 25-hydroxyvitamin D3-1-hydroxylase. Moreover, some evidence of mitochondrial localization of some alkaline phosphatases has been published. Although the existence of a levamisole inhibitable alkaline phosphatase activity has been described in renal cells, its role remains to be elucidated. In the present work, the existence of an alkaline phosphatase in mitochondrial membrane preparations from LLC-PK1 cells has been described. This alkaline phosphatase is magnesium dependent and levamisole inhibitable. Preparations of mitochondrial membrane from LLC-PK1 cells also showed 25-hydroxyvitamin D3-1-hydroxylase (1-hydroxylase) and 25-hydroxyvitamin D3-24R-hydroxylase (24-hydroxylase) activities being both enzymes responsive to the 8Br-cAMP mediated regulation. The 8Br-cAMP not only stimulated the 1-hydroxylase and inhibited the 24-hydroxylase activities but also increased the mitochondrial alkaline phosphatase activity. In the same way, the levamisole (specific inhibitor of some alkaline phosphatases) inhibited the mitochondrial alkaline phosphatase and also the 1-hydroxylase activity. In addition, the inhibition of mitochondrial alkaline phosphatase by levamisole avoids the effect of 8Br-cAMP on the 1-hydroxylase and 24-hydroxylase activities. On the other hand, the mitochondrial alkaline phosphatase and the 1-hydroxylase activities showed similar behaviour with respect to the magnesium concentrations in the incubation medium. Taking these results together it could be possible to suggest the implication of the Mg(2+)-dependent mitochondrial alkaline phosphatase activity found in LLC-PK1 cells in the regulation of the 1,25(OH)2D3 and 24,25(OH)2D3 synthesis.
Similar articles
- Mitochondrial alkaline phosphatase as an intracellular signal in the synthesis of 1,25(OH)2D3 and 24,25(OH)2D3 in LLC-PK1 cells.
Municio MJ, Traba ML. Municio MJ, et al. J Physiol Biochem. 2003 Dec;59(4):287-92. doi: 10.1007/BF03179886. J Physiol Biochem. 2003. PMID: 15164948 - Cloning of porcine 25-hydroxyvitamin D3 1alpha-hydroxylase and its regulation by cAMP in LLC-PK1 cells.
Yoshida T, Yoshida N, Nakamura A, Monkawa T, Hayashi M, Saruta T. Yoshida T, et al. J Am Soc Nephrol. 1999 May;10(5):963-70. doi: 10.1681/ASN.V105963. J Am Soc Nephrol. 1999. PMID: 10232681 - Vitamin D hydroxylases.
Henry HL. Henry HL. J Cell Biochem. 1992 May;49(1):4-9. doi: 10.1002/jcb.240490103. J Cell Biochem. 1992. PMID: 1644853 Review. - The 25(OH)D(3)/1alpha,25(OH)(2)D(3)-24R-hydroxylase: a catabolic or biosynthetic enzyme?
Henry HL. Henry HL. Steroids. 2001 Mar-May;66(3-5):391-8. doi: 10.1016/s0039-128x(00)00158-6. Steroids. 2001. PMID: 11179748 Review.
Cited by
- Hypomagnesemia: a potential underlooked cause of persistent vitamin D deficiency in chronic kidney disease.
Matias P, Ávila G, Ferreira AC, Laranjinha I, Ferreira A. Matias P, et al. Clin Kidney J. 2023 Jun 1;16(11):1776-1785. doi: 10.1093/ckj/sfad123. eCollection 2023 Nov. Clin Kidney J. 2023. PMID: 37915933 Free PMC article. Review. - Macromineral requirements for maintenance and growth in male and female hair sheep.
Herbster CJL, Abreu MLC, Brito Neto AS, Mendes MS, da Silva LP, Marcondes MI, Mazza PHS, Cabral LS, Bezerra LR, Oliveira RL, Pereira ES. Herbster CJL, et al. Front Vet Sci. 2023 Mar 2;10:1032429. doi: 10.3389/fvets.2023.1032429. eCollection 2023. Front Vet Sci. 2023. PMID: 36937008 Free PMC article. - Can Maintaining Optimal Magnesium Balance Reduce the Disease Severity of COVID-19 Patients?
Eskander M, Razzaque MS. Eskander M, et al. Front Endocrinol (Lausanne). 2022 Mar 29;13:843152. doi: 10.3389/fendo.2022.843152. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35422757 Free PMC article. No abstract available. - Association between magnesium intake and cognition in US older adults: National Health and Nutrition Examination Survey (NHANES) 2011 to 2014.
Tao MH, Liu J, Cervantes D. Tao MH, et al. Alzheimers Dement (N Y). 2022 Feb 1;8(1):e12250. doi: 10.1002/trc2.12250. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 35128033 Free PMC article. - Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial.
Dai Q, Zhu X, Manson JE, Song Y, Li X, Franke AA, Costello RB, Rosanoff A, Nian H, Fan L, Murff H, Ness RM, Seidner DL, Yu C, Shrubsole MJ. Dai Q, et al. Am J Clin Nutr. 2018 Dec 1;108(6):1249-1258. doi: 10.1093/ajcn/nqy274. Am J Clin Nutr. 2018. PMID: 30541089 Free PMC article. Clinical Trial.